Dr. Helge W. Thies (42), is head of Research and Development with Lipozyt Marker UG. He studied biology at the University of Bremen and graduated with a diploma (master) in 2009. After gaining his diploma, he worked as a research assistant for the Center of Human Genetics (ZHG) in Bremen and for a Dutch biotech company. Dr. Thies’ scientific research focused on mRNA analysis with regard to adipogenesis, dysfunctional adipose tissue and mesenchymal stem cell differentiation. He obtained his PhD in biology at the University of Bremen in 2014
Dr. Markus Klemke (38), is head of laboratory with Lipozyt Marker UG. He studied biology at the University of Bremen and graduated with a diploma (master) in 2006. Subsequently he worked as a researcher for a biotech company in Bremen, where he performed genetic analyses of different human tumours. Dr. Klemke was the head scientist in a research project for cancer markers in cooperation with a leading, globally acting German biotech company. He obtained his PhD in biology at the University of Bremen in 2014.
Uwe Jensen (61), is CEO of Lipozyt Marker UG. He is an expert in national and international R&D processes focussing on start-up and growth companies. Before setting up a consulting firm he worked for state owned companies and in the private oil and gas sector. He got his diploma in physics at the University of Göttingen and was trained in technical impact assessment, environmental protection and energy saving measures.
Wolfgang Hierneis (50), leads strategy and finance with Lipozyt Marker UG. He has more than 25 years of experience in financial advisory and strategic consultancy with start-up companies and SMEs. Prior to setting up his own business in 1998 he worked with a German private equity firm. He graduated as a master in economics at the University of Hamburg and completed a bank-traineeship.